DEPAS Safety Questions, DEPAS Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DEPAS. Our extensive database of DEPAS adverse events and DEPAS warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DEPAS
DEPAS Safety Reports
Total DEPAS reports: 10.DEPAS FDA safety alerts: No.
Reported hospitalizations: 7.
Take DEPAS Side Effects Survey or Share Your DEPAS Story. Read More Here.
Physician from JAPAN reported DEPAS problem on Apr 27, 2007. Male patient, 21 years of age, was diagnosed with insomnia, schizophrenia, parkinsonism and was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: epistaxis. DEPAS dosage: 0.5 MG, UNK. During the same period patient was treated with AMOBAN, ZYPREXA, IMPROMEN, AKINETON, NELBON. Patient recovered.
DEPAS problem was reported by a Physician from JAPAN on May 02, 2007. Male patient, 20 years of age, was diagnosed with insomnia, schizophrenia, parkinsonism and was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: epistaxis. DEPAS dosage: 0.5 MG, UNK. During the same period patient was treated with AMOBAN, ZYPREXA, IMPROMEN, AKINETON, NELBON. Patient recovered.
Physician from JAPAN reported DEPAS problem on May 14, 2007. Male patient, 20 years of age, was diagnosed with insomnia, schizophrenia, parkinsonism and was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: epistaxis. DEPAS dosage: 0.5 MG, UNK. During the same period patient was treated with AMOBAN, ZYPREXA, IMPROMEN, AKINETON, NELBON. Patient recovered.
DEPAS problem was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Male patient, weighting 8.38 lb, was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. DEPAS dosage: unknown. During the same period patient was treated with SOLANAX, LUDIOMIL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported DEPAS problem on July 14, 2006. Male patient, 60 years of age, was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. DEPAS dosage: unknown. During the same period patient was treated with LENDORMIN, MYSLEE, LOCHOL, ACINON, OLMETEC, CALBLOCK, FERROMIA, EBASTEL. Patient was hospitalized. Patient recovered.
DEPAS problem was reported by a Physician from JAPAN on July 14, 2006. Male patient, 60 years of age, was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. DEPAS dosage: unknown. During the same period patient was treated with LENDORMIN, MYSLEE, LOCHOL, ACINON, OLMETEC, CALBLOCK, FERROMIA, EBASTEL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported DEPAS problem on Sept 27, 2006. Female patient, 51 years of age, weighting 178.6 lb, was diagnosed with neuralgia and was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, eosinophil count increased, gallbladder disorder. DEPAS dosage: 1.5 MG/DAY. During the same period patient was treated with WARFARIN, SELBEX, TEGRETOL. Patient was hospitalized. Patient recovered.
DEPAS problem was reported by a Consumer or non-health professional from JAPAN on July 11, 2007. Female patient, 53 years of age, was diagnosed with suicide attempt and was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: blister, coma, overdose, skin ulcer, suicide attempt. DEPAS dosage: unknown. During the same period patient was treated with HALCION, LUDIOMIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported DEPAS problem on July 24, 2007. Female patient, 53 years of age, was diagnosed with suicide attempt and was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blister, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, coma, loss of consciousness, overdose, skin graft. DEPAS dosage: unknown. During the same period patient was treated with HALCION, LUDIOMIL. Patient was hospitalized. Patient recovered.
DEPAS problem was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2007. Male patient, weighting 8.38 lb, was treated with DEPAS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. DEPAS dosage: unknown. During the same period patient was treated with ALPRAZOLAM, LUDIOMIL. Patient was hospitalized. Patient recovered.